 |
John Dawson
Chief Executive Officer
John Dawson was appointed to Oxford BioMedica's board in 2008. From 1996 to 2007 he held senior management positions in the European operations of Cephalon Inc., including from 2005 a management board position as Chief Financial Officer and Head of Business Development Europe. In his time at Cephalon he led the many deals that built the European business to over 1,000 people, taking the business from having no sales in 1998 to a turnover of several hundred million US dollars. In 2005 he led the US$360 million acquisition of Zeneus by Cephalon.
|
Back
Website by College Hill - Life Sciences |
